Elon Musk's brain enhancement company got rejected for its plans to conduct human trials. In a supposed bid to put things underway, Elon Musk's Neuralink got rejected by the US Food and Drug Administration (FDA) in 2022 for its plans to move forward in testing its technology for humans.
Neuralink is focusing on morbid obesity and it is opening new positions for smartwatch makers. Neuralink is working on a new venture that will bring a health solution to a global problem that the world suffers from, with morbid obesity via its brain chips and other focus.